R A Krause - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

R A Krause

Showing results (1-10 of 10) with videos related to

Pageof 1

Sort By:

Strahlentherapie|November 1, 1980

[Dose requirement and definition of the image with new types of mammographic systems (author's transl)]D Frost, R A Krause

Mutation Research|December 1, 1986

Rhodium(III) complexes as genotoxic agents: photochemical effects and their implicationsJ M LaVelle, R A Krause

Research Communications in Chemical Pathology and Pharmacology|February 1, 1982

The effects of anti-inflammatory and other agents on the rat dermal arthus reactionG W Carter, M K Martin, R A Krause, et al.

Agents and Actions|August 1, 1987

High-level C5a gene expression and recovery of recombinant human C5a from Escherichia coliK W Mollison, T A Fey, R A Krause, et al.

Toxicology|May 7, 1998

Nephrotoxicity studies of the immunosuppressants tacrolimus (FK506) and ascomycin in rat modelsK W Mollison, T A Fey, R A Krause, et al.

Journal of Pharmacological and Toxicological Methods|May 22, 1998

Improved methods for transplanting split-heart neonatal cardiac grafts into the ear pinna of mice and ratsT A Fey, R A Krause, G C Hsieh, et al.

The Journal of Antibiotics|December 1, 1991

Dunaimycins, a new complex of spiroketal 24-membered macrolides with immunosuppressive activity. III. Immunosuppressive activities of dunaimycinsN S Burres, U Premachandran, A Frigo, et al.

Agents and Actions. Supplements|January 1, 1991

C5a structural requirements for neutrophil receptor interactionK W Mollison, T A Fey, R A Krause, et al.

Proceedings of the National Academy of Sciences of the United States of America|January 1, 1989

Identification of receptor-binding residues in the inflammatory complement protein C5a by site-directed mutagenesisK W Mollison, W Mandecki, E R Zuiderweg, et al.

The Journal of Pharmacology and Experimental Therapeutics|February 12, 1998

Discovery of less nephrotoxic FK506 analogs and determining immunophilin dependence of immunosuppressant nephrotoxicity with a novel single-dose rat cisplatin potentiation assayK W Mollison, T A Fey, R A Krause, et al.

Pageof 1

Search research articles

Showing results (1-10 of 10) with videos related to

Sort By:

Pageof 1

Strahlentherapie|November 1, 1980

[Dose requirement and definition of the image with new types of mammographic systems (author's transl)]D Frost, R A Krause

Mutation Research|December 1, 1986

Rhodium(III) complexes as genotoxic agents: photochemical effects and their implicationsJ M LaVelle, R A Krause

Research Communications in Chemical Pathology and Pharmacology|February 1, 1982

The effects of anti-inflammatory and other agents on the rat dermal arthus reactionG W Carter, M K Martin, R A Krause, et al.

Agents and Actions|August 1, 1987

High-level C5a gene expression and recovery of recombinant human C5a from Escherichia coliK W Mollison, T A Fey, R A Krause, et al.

Toxicology|May 7, 1998

Nephrotoxicity studies of the immunosuppressants tacrolimus (FK506) and ascomycin in rat modelsK W Mollison, T A Fey, R A Krause, et al.

Journal of Pharmacological and Toxicological Methods|May 22, 1998

Improved methods for transplanting split-heart neonatal cardiac grafts into the ear pinna of mice and ratsT A Fey, R A Krause, G C Hsieh, et al.

The Journal of Antibiotics|December 1, 1991

Dunaimycins, a new complex of spiroketal 24-membered macrolides with immunosuppressive activity. III. Immunosuppressive activities of dunaimycinsN S Burres, U Premachandran, A Frigo, et al.

Agents and Actions. Supplements|January 1, 1991

C5a structural requirements for neutrophil receptor interactionK W Mollison, T A Fey, R A Krause, et al.

Proceedings of the National Academy of Sciences of the United States of America|January 1, 1989

Identification of receptor-binding residues in the inflammatory complement protein C5a by site-directed mutagenesisK W Mollison, W Mandecki, E R Zuiderweg, et al.

The Journal of Pharmacology and Experimental Therapeutics|February 12, 1998

Discovery of less nephrotoxic FK506 analogs and determining immunophilin dependence of immunosuppressant nephrotoxicity with a novel single-dose rat cisplatin potentiation assayK W Mollison, T A Fey, R A Krause, et al.

Pageof 1